CPSF7

Cleavage and polyadenylation specificity factor subunit 7 · Q8N684 · CPSF7 on Sugi Atlas →

0 patent compounds predicted against CPSF7, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CPSF7 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Acelarin First Line Randomised Pancreatic Study PHASE2/PHASE3SUSPENDED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer PHASE2ACTIVE_NOT_RECRUITING
A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib PHASE2COMPLETED
AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications. PHASE1/PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors PHASE1COMPLETED
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping nanUNKNOWN
Circulating Markers for Ischemic Heart Disease nanRECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Study to Explore Natural Daily Variation and Impact of Stress in HIV Levels nanCOMPLETED
Study of Constitutional Platelet Disease nanUNKNOWN
Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab nanCOMPLETED
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 nanCOMPLETED
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Identification of Viable Human Embryos Using Three Different Methods nanCOMPLETED
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
Study of Sperm Molecular Factors Implicated in Male Fertility nanCOMPLETED
DNA Damage & Repair Proteins In Patients With Atherosclerotic Coronary Artery Disease nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CPSF7 binder may also engage these)

ProteinNameSimilarity
Q8BTV2 1.000 Q8BTV2 →
Q5XI29 1.000 Q5XI29 →
Q5NVH8 0.997 Q5NVH8 →
Q5ZL34 0.996 Q5ZL34 →
Q6NVF9 0.996 Q6NVF9 →
Q6NWC6 0.996 Q6NWC6 →
CPSF6 Cleavage and polyadenylation specificity factor subunit 6 0.994 landscape →
Q0P5D2 0.994 Q0P5D2 →
Q6DDW4 0.990 Q6DDW4 →
Q5TYQ8 0.990 Q5TYQ8 →
SMARCC2 SWI/SNF complex subunit SMARCC2 0.989 landscape →
A0A086T5L8 0.989 A0A086T5L8 →
I1S537 0.988 I1S537 →
P97868 0.988 P97868 →
A1DFP5 0.988 A1DFP5 →
Q9WVR4 0.987 Q9WVR4 →
Q9FFQ0 0.987 Q9FFQ0 →
A1CX69 0.987 A1CX69 →
F4JP52 0.987 F4JP52 →
RBM26 RNA-binding protein 26 0.987 landscape →
A2QWA2 0.987 A2QWA2 →
B8NIF0 0.987 B8NIF0 →
Q69B22 0.987 Q69B22 →
U2SURP U2 snRNP-associated SURP motif-containing protein 0.986 landscape →
Q2T9I5 0.986 Q2T9I5 →
A1CEK1 0.986 A1CEK1 →
Q0VFM0 0.986 Q0VFM0 →
P53990 0.986 P53990 →
Q8VD37 0.986 Q8VD37 →
Q8K0V4 0.986 Q8K0V4 →